Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained
Please read the full announcement in PDF Attachment 2023_Conditional_competition_clearance_from_the_EC
Comunicato Precedente
Comunicato Successivo
Please read the full announcement in PDF
Attachment
- 2023_Conditional_competition_clearance_from_the_EC
Per maggiori informazioni
Sito Web
novozymes.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
;
